13159-46-1 butanoic acid, 4,4,4-trichloro-3-hydroxy-
131596-19-5 PDI protein
131600-18-5 O
131601-90-6 CYCLOHEXANECARBONYL CHLORIDE,2-METHOXY-,(1R-CIS)-
131604-12-1 3-({4-[(4-methylpiperazin-1-yl)carbonyl]phenyl}amino)-2-phenylquinazolin-4(3H)-one
131604-18-7 4-[(7-bromo-4-oxo-2-phenylquinazolin-3(4H)-yl)amino]-N,N-bis(2-hydroxyethyl)benzamide
131610-12-3 2(1H)-Quinolinone,6-fluoro-1,3-dimethyl-
131610-90-7 EO 5A
131610-99-6 Hydrazinecarboximidamide,N-hydroxy-2-[(2-hydroxy-5-nitrophenyl)methylene]-,mono(4-methylbenzenesulfonate) (salt)
131613-17-7 5-methyl-6-[(2E)-3-methylpent-2-en-4-yn-1-yl]-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2-ol
13161-35-8 Urs-12-en-3β-ol 3-phenylpropenoate
131619-07-3 1,3-bis((2-(((acetoxymethyl)oxy)carbonyl)chromon-5-yl)oxy)-2-hydroxypropane
131619-09-5 2-{4-[(2-hydroxycyclohexyl)oxy]phenyl}-2-methylpropanoic acid
131619-12-0 sodium 2-{4-[(2,2-dihydroxycyclohexyl)oxy]phenyl}-2-methylpropyl sulfate
1316214-52-4 ACY-1215
131622-07-6 Nd.O.Zr
Contacter Mrs.Camila Email Us
Mobile +86 18136843696
Tel +86 25 5874 5998
QQ 3461339351
WeChat +86 18136843696
Skype live:.cid.6d3c4ae5f7de0a26
Social Media
Serving Advanced Chemicals to Global Customers
© 2009 - 2025 USCKS | King-Pharm Ver 3.0